–Big milestone achieved with fruquintinib successfully approved by US FDA
India's Export Ambitions: Trade Strategy to Achieve US$ 2 Trillion by 2030
Achieving Sustainable and Inclusive Artisanal and Small-Scale Mining (ASM)
Back to capex growth model to achieve product diversification & overseas expansion
Better profits achieved across 3 business lines
Sales exceeding expectations and achieving non-GAAP profitability
More visible path to achieve profitability; U/G to BUY
2Q24 sales volume +1%; Full-year target still achievable